Evidence map›Paper›PMID 36742052›Full record

ArticleFrontiers in neurology2022

Development and external validation of a prognostic model for occult atrial fibrillation in patients with ischemic stroke.

Xuan Wang, Longyan Meng, Yanxin Zhao, Xueyuan Liu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Xuan WangDepartment of Neurology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Longyan MengDepartment of Neurology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Yanxin ZhaoDepartment of Neurology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Xueyuan LiuDepartment of Neurology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
Tongji University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Currently, the risk of occult atrial fibrillation (AF) could not be predicted in patients with acute ischemic stroke (AIS) using a simple scoring system. Therefore, in this study, we developed and externally validated a nomogram to predict occult AF in patients with AIS. Methods: In this study, we prospectively conducted a development cohort study with data collected at our stroke center from July 2017 to February 2018, and an external validation cohort from March 2019 to December 2019. Results: Follow-up data were collected from 177 participants (56.5% older than 65 years, 29.4% female) for generating the nomogram model. Multivariate logistic regression analysis was performed with AF as the dependent variable indicated that age >65 years, heart rate >100, C-reactive protein (CRP), N-terminal pro-B-type natriuretic peptide (NT-proBNP) >270, hemorrhagic transformation (HT) as independent variables for predicting the development of AF, and a nomogram was generated based on these factors. The area under the receiver operating characteristic curve (AUC-ROC) for the model was 0.937, the C-index was 0.926, and the AUC-ROC for the validation cohort was 0.913. Conclusion: To our knowledge, this is the first nomogram developed and externally validated in a stroke center cohort for individualized prediction of risk of developing AIS in patients with occult AF. This nomogram could provide valuable information for the screening of occult AF after a stroke.

Indexed as

acute ischemic strokecardioembolismnomogramoccult atrial fibrillationsecondary prevention

Identifiers

PMID36742052
PMCPMC9891292
OpenAlexW4317395575

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.